About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Shut-Off Switch Can Prevent Tumor Formation

by Hannah Joy on December 7, 2017 at 5:32 PM
Font : A-A+

Shut-Off Switch Can Prevent Tumor Formation

Defective T cells were found to have an emergency shut-off switch known as a tumor suppressor, which can prevent the defective T cells from becoming tumor cells, reveals a new study.

Safety switches that automatically stop the device for example before it overheats are built into many electrical appliances. Cells are also equipped with such "emergency stop" functions. They make sure that a defective cell doesn't become a tumor cell.

Advertisement


A team from Technical University of Munich has now discovered such a switch in T cells. These results can help to find new therapies against T cell Non-Hodgkin's lymphoma triggered by defective immune cells.

In the body T cells are usually responsible for immediately detecting and killing cancer cells. However, problems can arise when a T cell itself develops a defect in its genome, the DNA. If the defect affects areas of the genome which are responsible for cell growth, referred to as oncogenes, the T cell itself can become an uncontrollably growing tumor cell. In addition, the T cell, an important part of the body's immune system against cancer, fails.
Advertisement

This is exactly what occurs in T cell Non-Hodgkin's lymphoma. This aggressive form of lymphoma has a very low rate of successful treatment and afflicts approximately one out of every 100,000 persons in Germany.

Prof. Jürgen Ruland, Director of the TUM Institute for Clinical Chemistry and Pathobiochemistry and Principal Investigator at the TUM Central Institute for Translational Cancer Research (TranslaTUM) and at the German Cancer Consortium (DKTK), is working together with his team to precisely understand the molecular mechanisms of these cancers in order to be able to treat them more effectively.

PD-1 as the shut-off switch in tumor formation

In their new study, currently published in the journal Nature, the scientists succeeded in a very important step: They were able to show that the defective T cells also have an emergency shut-off switch, referred to as a tumor suppressor. They ascertained that the protein PD-1 can turn off defective T cells at an early stage and thus prevent them from becoming tumor cells.

The researchers first discovered this function of PD-1 in a mouse model for T cell Non-Hodgkin's lymphoma and were also able to explain the mechanism: PD-1 is activated by defects in genes for cell growth, known as oncogenes, and then suppresses the effect of these genes using additional proteins. Thus it functions as a shut-off switch to prevent the uncontrolled growth of defective T cells.

Tumor analysis helps in deciding on therapies

Then the scientists also successfully resolved the question of why many T cell Non-Hodgkin's lymphomas are so aggressive, in spite of this protective function. They investigated genetic data sets from 150 patients:

"Based on our previous results, we intentionally focused closely on PD-1. In individual groups more than 30 % of the patients exhibited changes in the regions of the genome which interfered with the production of PD-1. This has disastrous consequences in the tumor - PD-1 no longer functions as an 'emergency shut-off' for them. The diseased T cells can reproduce uncontrollably," explains Tim Wartewig, lead author of the study.

"These patients could be helped by medications that reverse the loss of PD-1 signaling and thereby destroy the tumor cells. This type of medication already exists for other forms of cancer - In our opinion, use with T cell Non-Hodgkin's lymphoma should also be considered," says Jürgen Ruland.

The scientists therefore recommend investigating individual differences in tumors before making decisions about which medication is to be administered.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
Long-Term Glycemic Control - A Better Measure of COVID-19 Severity
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Tumor Markers For Cancer Diagnosis and Prognosis 

Recommended Reading
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of ....
Organ Transplant Recipients at Increased Cancer Risk
Patients who have received a solid organ transplant, such as kidney, liver, heart or lung, have an ....
Genetic Changes Increase Risk of Developing Hodgkin Lymphoma
Hodgkin lymphoma, one of the most common cancers in young adults can increase their risk of this ......
Tumor Markers For Cancer Diagnosis and Prognosis
An ideal tumor marker for a cancer should be specific to that cancer and not generate false positive...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use